PARP1 and neoplasm: Furthermore, not all BRCA mutant tumours are HR deficient and many HR-proficient tumours can initially respond well to PARPi [40,41,42,43,44] which has been attributed to the involvement of PARP in other non-DDR associated mechanisms including chromatin remodelling [45].